Miraculins Signs Letter of Intent With New Leaf Health

July 31, 2015

Miraculins Inc. (MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, today announces the execution of a non-binding Letter of Intent (the "LOI") with New Leaf Health Ltd. ("New Leaf"), one of the largest, most experienced workplace wellness providers in the United Kingdom (UK), for the exclusive distribution of the Scout DS(R) diabetes screen into the UK workplace wellness segment.

Read on for the full story. 

Share This Story